107 related articles for article (PubMed ID: 9466319)
1. The analysis of steroidogenic activity in non-hyperfunctioning adrenocortical adenoma.
Morioka M; Tanaka H; Ohashi Y; Jin TX; Komatsu F; Watanabe H
Endocr J; 1997 Oct; 44(5):647-53. PubMed ID: 9466319
[TBL] [Abstract][Full Text] [Related]
2. ACTH-independent macronodular adrenocortical hyperplasia (AIMAH): report of two cases and the analysis of steroidogenic activity in adrenal nodules.
Morioka M; Ohashi Y; Watanabe H; Komatsu F; Jin TX; Suyama B; Tanaka H
Endocr J; 1997 Feb; 44(1):65-72. PubMed ID: 9152616
[TBL] [Abstract][Full Text] [Related]
3. Significance of steroidogenic enzymes in the pathogenesis of hyperfunctioning and non-hyperfunctioning adrenal tumor.
Suzuki H; Shibata H; Maruyama T; Ishimura Y; Saruta T
Steroids; 1995 Jan; 60(1):42-7. PubMed ID: 7792814
[TBL] [Abstract][Full Text] [Related]
4. Significance of steroidogenic enzymes in the pathogenesis of adrenal tumour.
Shibata H; Suzuki H; Ogishima T; Ishimura Y; Saruta T
Acta Endocrinol (Copenh); 1993 Mar; 128(3):235-42. PubMed ID: 8480473
[TBL] [Abstract][Full Text] [Related]
5. Disordered expression of adrenal steroidogenic P450 mRNAs in incidentally discovered nonfunctioning adrenal adenoma.
Ogo A; Haji M; Ohashi M; Takayanagi R; Yanase T; Nawata H
Endocrinol Jpn; 1992 Feb; 39(1):73-80. PubMed ID: 1535042
[TBL] [Abstract][Full Text] [Related]
6. Steroid contents and cortical steroidogenic enzymes in non-hyperfunctioning adrenal adenoma.
Suzuki H; Shibata H; Takita T; Wakino S; Ogishima T; Ishimura Y; Saruta T
Endocr J; 1994 Jun; 41(3):267-74. PubMed ID: 7951578
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical demonstration of cholesterol side-chain cleavage cytochrome P-450 in bovine and human adrenals.
Sasano H; Sasano N; Okamoto M
Pathol Res Pract; 1989 Mar; 184(3):337-42. PubMed ID: 2748459
[TBL] [Abstract][Full Text] [Related]
8. Immunolocalization of glutathione-peroxidase (GSH-PO) in human adrenal gland--studies on adrenocortical adenomas associated with primary aldosteronism and Cushing's syndrome.
Murakoshi M; Osamura RY; Yoshimura S; Watanabe K
Tokai J Exp Clin Med; 1995 Jul; 20(2):89-97. PubMed ID: 8797265
[TBL] [Abstract][Full Text] [Related]
9. Deoxycorticosterone and aldosterone excretion in Cushing's syndrome.
Cassar J; Loizou S; Kelly WF; Mashiter K; Joplin GF
Metabolism; 1980 Feb; 29(2):115-9. PubMed ID: 7354720
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics of Itsenko-Cushing syndrome with various morphological changes in the adrenal cortex].
Baranov VG; Nechaĭ AI; Trofimov VM; Savushkina AS; Kalashnikov SA
Probl Endokrinol (Mosk); 1986; 32(3):30-4. PubMed ID: 3016700
[TBL] [Abstract][Full Text] [Related]
11. Gene expression of angiotensin II receptor in blood cells of Cushing's syndrome.
Shibata H; Suzuki H; Maruyama T; Saruta T
Hypertension; 1995 Dec; 26(6 Pt 1):1003-10. PubMed ID: 7490136
[TBL] [Abstract][Full Text] [Related]
12. Hypertension and aldosterone overproduction without renin suppression in Cushing's syndrome from an adrenal adenoma.
Guthrie GP; Kotchen TA
Am J Med; 1979 Sep; 67(3):524-8. PubMed ID: 474601
[TBL] [Abstract][Full Text] [Related]
13. Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in vivo and in vitro studies.
Tsagarakis S; Tsigos C; Vassiliou V; Tsiotra P; Pratsinis H; Kletsas D; Trivizas P; Nikou A; Mavromatis T; Sotsiou F; Raptis S; Thalassinos N
J Clin Endocrinol Metab; 2001 Feb; 86(2):583-9. PubMed ID: 11158012
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of dissociation of cortisol and adrenal androgen secretion after removal of adrenocortical adenoma in patients with Cushing's syndrome.
Nawata H; Higuchi K; Yanase T; Takayanagi R; Kato K; Ibayashi H
Endocrinol Jpn; 1985 Oct; 32(5):691-700. PubMed ID: 2936600
[TBL] [Abstract][Full Text] [Related]
15. A patient with preclinical Cushing's syndrome and excessive DHEA-S secretion having unilateral adrenal carcinoma and contralateral adenoma.
Midorikawa S; Hashimoto S; Kuriki M; Katoh K; Watanabe T; Sasano H; Nishikawa T
Endocr J; 1999 Feb; 46(1):59-66. PubMed ID: 10426568
[TBL] [Abstract][Full Text] [Related]
16. Double adenomas with different pathological and hormonal features in the left adrenal gland of a patient with Cushing's syndrome.
Satoh F; Murakami O; Takahashi K; Ueno J; Nishikawa T; Abe K; Mouri T; Sasano H
Clin Endocrinol (Oxf); 1997 Feb; 46(2):227-34. PubMed ID: 9135707
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Cushing's syndrome resulting from black adrenal adenoma. A case report.
Tokunagaa H; Miyamura N; Sasaki K; Yoshizato K; Itasaka M; Nakamaru K; Suefuji M; Kawashima J; Matsumoto K; Sasano H; Araki E
Horm Res; 2004; 62(2):60-6. PubMed ID: 15211088
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of cytochrome P-45017 alpha in human adrenocortical disorders.
Sasano H; Mason JI; Sasano N
Hum Pathol; 1989 Feb; 20(2):113-7. PubMed ID: 2914700
[TBL] [Abstract][Full Text] [Related]
19. Endocrine activity of the "silent" adrenocortical adenoma is uncovered by response to corticotropin-releasing hormone.
Hensen J; Buhl M; Bähr V; Oelkers W
Klin Wochenschr; 1990 Jun; 68(12):608-14. PubMed ID: 2165544
[TBL] [Abstract][Full Text] [Related]
20. High expression of cytochrome b5 in adrenocortical adenomas from patients with Cushing's syndrome associated with high secretion of adrenal androgens.
Sakai Y; Yanase T; Takayanagi R; Nakao R; Nishi Y; Haji M; Nawata H
J Clin Endocrinol Metab; 1993 May; 76(5):1286-90. PubMed ID: 8496319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
